U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360275) titled 'A Study of VCT220 in Participants With Hypertension and Obesity or Overweight' on Jan. 09.
Brief Summary: The purpose of this study is to explore the safety and efficacy of VCT220 for the treatment of hypertension in participants with obesity or overweight.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Hypertension
Intervention:
DRUG: VCT220 Tablet
Administered orally, with or without food.
DRUG: VCT220 Placebo Tablet
Administered orally, with or without food.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vincentage Pharma Co., Ltd
Disclaimer: Curated by HT Syndication....